超越寡转移 - Suppr

Beyond Oligometastases.

作者信息

Palma David A, Bauman Glenn S, Rodrigues George B

机构信息

Division of Radiation Oncology, Western University, London, Canada.

出版信息

Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):253-256. doi: 10.1016/j.ijrobp.2019.12.023.

DOI:10.1016/j.ijrobp.2019.12.023

PMID:32386735

Abstract

摘要

相似文献

Beyond Oligometastases.

Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):253-256. doi: 10.1016/j.ijrobp.2019.12.023.

A rationale for the targeted treatment of oligometastases with radiotherapy.

J Surg Oncol. 2008 Sep 1;98(3):202-6. doi: 10.1002/jso.21102.

[Stereotactic body radiotherapy of oligometastases: Main pending trials and to come in France].

Cancer Radiother. 2019 Oct;23(6-7):496-499. doi: 10.1016/j.canrad.2019.07.124. Epub 2019 Aug 27.

Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastases.

J Clin Oncol. 2009 Apr 1;27(10):1537-9. doi: 10.1200/JCO.2008.21.7299. Epub 2009 Mar 2.

Immunotherapy and radiotherapy for metastatic cancers.

Ann Palliat Med. 2019 Jul;8(3):312-325. doi: 10.21037/apm.2018.07.10. Epub 2018 Aug 22.

Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis.

Anticancer Res. 2015 May;35(5):3055-9.

[Stereotactic body radiation therapy and oligometastases].

Cancer Radiother. 2014 Jul-Aug;18(4):337-41. doi: 10.1016/j.canrad.2014.02.008. Epub 2014 May 1.

Stereotactic body radiotherapy for oligometastases confined to the para-aortic region: clinical outcomes and the significance of radiotherapy field and dose.

Cancer Invest. 2015 May;33(5):180-7. doi: 10.3109/07357907.2015.1019678. Epub 2015 Apr 1.

The Evolution (and Future) of Stereotactic Body Radiotherapy in the Treatment of Oligometastatic Disease.

Hematol Oncol Clin North Am. 2020 Feb;34(1):307-320. doi: 10.1016/j.hoc.2019.09.003. Epub 2019 Oct 28.

Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression.

Radiother Oncol. 2018 Jun;127(3):493-500. doi: 10.1016/j.radonc.2018.04.022. Epub 2018 May 4.

引用本文的文献

Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204).

BMC Cancer. 2025 Aug 18;25(1):1336. doi: 10.1186/s12885-025-13892-9.

Technical feasibility of novel immunostimulatory low-dose radiation for polymetastatic disease with CBCT-based online adaptive and conventional approaches.

J Appl Clin Med Phys. 2024 Jun;25(6):e14303. doi: 10.1002/acm2.14303. Epub 2024 Feb 20.

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.

J Clin Invest. 2023 May 15;133(10):e162260. doi: 10.1172/JCI162260.

Stereotactic radiotherapy of oligometastatic disease: a new paradigm for a curative approach.

Rep Pract Oncol Radiother. 2022 May 19;27(2):376-378. doi: 10.5603/RPOR.a2022.0017. eCollection 2022.

Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer.

Cancers (Basel). 2022 Aug 17;14(16):3977. doi: 10.3390/cancers14163977.

Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review.

J Thorac Dis. 2022 Jul;14(7):2677-2688. doi: 10.21037/jtd-22-239.

The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease.

Semin Radiat Oncol. 2022 Apr;32(2):135-141. doi: 10.1016/j.semradonc.2021.11.009.

Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial.

Adv Radiat Oncol. 2021 Jun 5;6(5):100734. doi: 10.1016/j.adro.2021.100734. eCollection 2021 Sep-Oct.

Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease.

Front Oncol. 2021 Jun 15;11:667993. doi: 10.3389/fonc.2021.667993. eCollection 2021.

Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy.

BMC Cancer. 2021 Apr 14;21(1):405. doi: 10.1186/s12885-021-08020-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Beyond Oligometastases.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Beyond Oligometastases.

作者信息

机构信息

出版信息

相似文献

引用本文的文献